FibroGen Inc (FGEN)
12.80
-0.04 -0.31%
NASDAQ
Jul 30, 09:07
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 190.35M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.02 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -182.70M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 91.15% |
| Profit Margin (Quarterly) | -186.7% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 1.179B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 6.153 |
| PE Ratio | -- |
| Price to Book Value | 3.179 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Free Cash Flow (Quarterly) | -45.50M |
| Return on Equity | Upgrade |
View All FGEN News
News
-
WireHeadlineTime (ET)
-
Yahoo07/29 15:05
-
Yahoo07/29 07:00
-
Yahoo07/29 06:12
-
Yahoo07/26 17:09
-
Yahoo07/19 19:04
-
MT Newswires07/19 09:01
-
Globe Newswire07/19 07:00
-
Yahoo07/17 03:54
-
Yahoo07/16 16:13
-
MT Newswires07/16 15:57
-
MT Newswires07/16 15:41
-
Yahoo07/16 13:38
-
MT Newswires07/16 13:15
-
MT Newswires07/16 12:48
-
SA Breaking News07/16 12:34
-
Yahoo07/16 11:16
-
MT Newswires07/16 11:07
-
SA Breaking News07/16 11:01
-
MT Newswires07/16 09:54
-
MT Newswires07/16 09:19
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/06/2021 | Earnings Results | Q2 2021 Earnings Results |
| 08/06/2021 17:00 EST | Earnings Calls | Q2 2021 Earnings Call |
| 05/26/2021 15:00 EST | AGM | 2020 Annual General Meeting |
| 05/10/2021 | Earnings Results | Q1 2021 Earnings Results |
| 05/10/2021 17:00 EST | Earnings Calls | Q1 2021 Earnings Call |
| 03/01/2021 | Earnings Results | Q4 2020 Earnings Results |
| 03/01/2021 17:00 EST | Earnings Calls | Q4 2020 Earnings Call |
| 11/05/2020 | Earnings Results | Q3 2020 Earnings Results |
| 11/05/2020 17:00 EST | Earnings Calls | Q3 2020 Earnings Call |
| 08/06/2020 17:00 EST | Earnings Calls | Q2 2020 Earnings Call |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.
- URL: https://www.fibrogen.com
- Investor Relations URL: https://investor.fibrogen.com
- HQ State/Province: California
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Growth
- Next Earnings Release: Aug. 06, 2021
- Last Earnings Release: May. 10, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 12.80 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| QBTL.TO | AGFiQ US Market Neutral Anti-Bt CAD-HETF | 0.18% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- FGEN Tweets Stocktwits
Advertisement
